Prognostic Impact of Baseline Serum C-Reactive Protein in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib

Prognostic Impact of Baseline Serum C-Reactive Protein in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib

To evaluate the impact of baseline serum C-reactive protein (CRP) level on outcome in metastatic renal cell carcinoma (mRCC) patients treated with sunitinib.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJU International 2014-07, Vol.114 (1), p.81-9
Hauptverfasser: Beuselinck, Benoit, Vano, Yann-Alexandre, Oudard, Stéphane, Wolter, Pascal, De Smet, Robert, Depoorter, Lore, Teghom, Corine, Karadimou, Alexandra, Zucman-Rossi, Jessica, Debruyne, Philip R, Van Poppel, Hendrik, Joniau, Steven, Lerut, Evelyne, Strijbos, Michiel, Dumez, Herlinde, Paridaens, Robert, Van Calster, Ben, Schöffski, Patrick
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate the impact of baseline serum C-reactive protein (CRP) level on outcome in metastatic renal cell carcinoma (mRCC) patients treated with sunitinib.
ISSN:1464-4096